Compare iShares China Large-Cap ETF (FXI) vs Janus Living Inc. Class A-1 Common Stock (JAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares China Large-Cap ETF vs Janus Living Inc. Class A-1 Common Stock — how do they compare? iShares China Large-Cap ETF trades at $33.83 (market cap $3.93B), while Janus Living Inc. Class A-1 Common Stock trades at $29.12 (market cap $6.76B). The key difference: Janus Living Inc. Class A-1 Common Stock is the larger of the two by market cap, and Janus Living Inc. Class A-1 Common Stock pays a 1.98% dividend while iShares China Large-Cap ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 151 Days and Janus Living Inc. Class A-1 Common Stock for 0 Days on average.
| FXI | JAN | |
|---|---|---|
Market Cap | $3.93B | $6.76B |
Volume | 14,707,409 | 1,332,082 |
52-Week High | $41.08 | $31.76 |
52-Week Low | $31.59 | $22.88 |
Typical Hold Time | 151 Days | 0 Days |
Sector | — | Real Estate |
Enterprise Value | — | $6.85B |
Dividend Yield | — | 1.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FXI, the iShares China Large-Cap ETF, trades at $34.17 with minimal daily movement (+0.09%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. Recent news highlights China's mixed economic signals, including strong corporate profit growth but concerns over industrial overcapacity and trade tensions. The ETF offers value exposure with a P/E ratio approximately half that of the S&P 500, but faces significant geopolitical and economic headwinds.
The outlook for FXI remains clouded by US-China relations and domestic economic challenges. Investment opportunity lies in its valuation discount versus US equities and potential policy support from Chinese authorities. Key risks include escalating trade protectionism, weak domestic consumption, and regulatory uncertainty. Analyst sentiment is divided, reflecting the high-risk, high-reward nature of Chinese large-cap exposure.
JAN trades at $28.85, up 0.42% today, with a neutral technical signal. The company, a senior housing REIT, reported a net loss of $61.10M in 2025, though revenue grew to $771.17M. Analyst sentiment is strongly positive with a 100% buy rating and a $32.91 consensus price target, representing a 14% upside. Recent developments include closing a $1.25 billion credit facility and declaring quarterly dividends.
The outlook is cautiously optimistic, driven by strong analyst support and strategic growth initiatives. Key opportunities include accretive acquisitions funded by recent capital raises. Risks include persistent negative profit margins, execution challenges in integrating new assets, and sensitivity to interest rate changes affecting REIT valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →About Janus Living Inc. Class A-1 Common Stock
Janus Living, Inc. is a real estate investment trust that owns and operates senior housing communities in US. Its portfolio comprises roughly 34 communities across 10 states, structured under RIDEA arrangements and externally managed by Healthpeak Investment Management.
Read more on JAN →
